디앤디파마텍

347850KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

43,300KRWMarket close of 10/21 (Wed)

Up +6.65%+2,700KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)41,100KRWDown -5.08%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
41,000
High
43,300
Low
40,950
Day range
Day range low 40,950 high 43,300, open 41,000, close 43,300, previous close 40,600
Volume
52×10K shares
22.0B KRW 0.92× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 35,400 to 111,200 won, 10% up from the low

10% of the way up from the lowest close in 1 year (227 sessions) · -61.1% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-37.6B KRWOperating income over the last four quarters -37.6B KRW (loss)Operating income, 8 quarters
  • Daily moveusual range+6.65%+6.65%, 1.5× the usual (20-session average ±4.50%)
    That day +6.65% · usual ±4.50% · large-move threshold ±9.0%
  • Trading valueusual range0.9×22.0B KRW, 0.9× the 20-session average
    0.92× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+4.8B KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW
알지노믹스Close over the last 20 sessions -8.9%Up +7.26%10.5B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 24 days
  • Next data 10/23 (Fri) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.